sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
SYRE
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| SYRE Spyre Therapeutics, Inc. | Sale | $2,633,902 | King-Jones Heidy See Remarks | 28,933 sh | at $91.03 | Filed Oct 2, 9:30 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $1,380,105 | Turtle Cameron Chief Executive Officer, Director | 15,000 sh | at $92.01 | Filed Oct 2, 9:29 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $2,261,831 | Burrows Scott L Chief Financial Officer | 25,000 sh | at $90.47 | Filed Oct 2, 9:29 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $2,480,529 | King-Jones Heidy See Remarks | 28,399 sh | at $87.35 | Filed Sep 3, 9:34 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $2,283,821 | Burrows Scott L Chief Financial Officer | 25,732 sh | at $88.75 | Filed Sep 3, 9:33 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $1,309,410 | Turtle Cameron Chief Executive Officer, Director | 15,000 sh | at $87.29 | Filed Sep 3, 9:33 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $2,404,190 | Albers Jeffrey W. Director | 23,000 sh | at $104.53 | Filed Aug 10, 9:31 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $716,771 | Burrows Scott L Chief Financial Officer | 7,500 sh | at $95.57 | Filed Aug 5, 9:32 PM ET | Filing | |
| SYRE Spyre Therapeutics, Inc. | Sale | $1,432,705 | Turtle Cameron Chief Executive Officer, Director | 15,000 sh | at $95.51 | Filed Aug 5, 9:31 PM ET | Filing |